There is a molecule inside every cell of your body that determines how well that cell produces energy, repairs its own DNA, defends against oxidative stress, and communicates with the rest of your biology. It is not a hormone. It is not a vitamin. It is a coenzyme called NAD+ — nicotinamide adenine dinucleotide — and by the time you reach 40, your levels have dropped by roughly half.
That decline is not trivial. It is one of the most well-documented biochemical shifts associated with aging, and it touches virtually every system in the body: brain function, metabolic health, immune regulation, cardiovascular integrity, and hormonal balance. The research connecting NAD+ depletion to age-related disease has exploded over the past decade, and what it reveals is both sobering and genuinely hopeful.
Sobering because NAD+ loss is universal and progressive. Hopeful because it is directly replenishable — and NAD+ IV therapy is the most efficient way to do it.
To understand why NAD+ therapy produces the effects it does, you need to understand what NAD+ does at the cellular level. It is not a single-function molecule. It is a master regulator involved in hundreds of enzymatic reactions, and its influence extends across four critical domains.
Every cell in your body generates energy through the mitochondria — the organelles often called cellular power plants. NAD+ is an essential substrate in this process. It shuttles electrons through the mitochondrial electron transport chain, enabling the conversion of nutrients from food into ATP, the energy currency your cells run on. Without adequate NAD+, mitochondrial output drops. The subjective experience of that drop is what most people describe as chronic fatigue — a bone-deep tiredness that sleep does not resolve, because the problem is not rest. The problem is cellular fuel production.
Your DNA accumulates damage every day from UV exposure, metabolic byproducts, environmental toxins, and simple replication errors. The enzymes responsible for repairing that damage — particularly a family called PARPs (poly ADP-ribose polymerases) — require NAD+ as their primary fuel. When NAD+ is depleted, DNA repair slows. Damaged DNA accumulates. This is not abstract biology. It is one of the primary mechanisms driving cellular aging, cancer risk, and tissue degeneration.
Sirtuins are a family of seven proteins that have been called longevity regulators. They influence gene expression, inflammatory response, stress resistance, and metabolic efficiency. Every sirtuin depends on NAD+ to function. When NAD+ levels are high, sirtuins are active — silencing genes that promote inflammation, enhancing mitochondrial biogenesis (the creation of new mitochondria), and improving cellular stress response. When NAD+ is low, sirtuin activity declines, and the balance tips toward accelerated aging.
NAD+ levels naturally oscillate throughout the day, and this oscillation is tightly linked to your circadian clock. The relationship is bidirectional: your circadian rhythm influences NAD+ production, and NAD+ levels influence circadian gene expression. As NAD+ declines with age, circadian disruption follows — contributing to the sleep fragmentation, daytime fatigue, and impaired recovery that so many adults over 40 experience.
NAD+ is not a supplement trend. It is a foundational molecule that your cells need in order to perform the most basic functions of energy production, repair, and self-regulation. When it declines, everything downstream declines with it.
NAD+ depletion is partly a function of time. As you age, the enzymes that synthesize NAD+ become less efficient, while the enzymes that consume it — particularly CD38, an immune cell enzyme — become more active. The result is a widening gap between supply and demand.
But age is not the only factor. Several conditions accelerate NAD+ loss beyond what chronological aging alone would predict:
This means that the patients who most need NAD+ replenishment — those dealing with fatigue, cognitive decline, metabolic issues, or chronic stress — are often the ones whose NAD+ has declined the fastest.
If NAD+ is so critical, why not just take a supplement? This is one of the most common questions patients ask, and the answer lies in biochemistry and bioavailability.
The most widely marketed NAD+ supplements are not actually NAD+. They are precursors — molecules like NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) that must be converted into NAD+ through multiple enzymatic steps after absorption. The conversion pathway looks like this: oral ingestion, survival through stomach acid, absorption through the intestinal lining, hepatic first-pass metabolism, and then enzymatic conversion through the salvage pathway.
Each step introduces variability. Gut health, liver function, enzyme availability, and individual genetics all influence how much of an oral precursor actually becomes usable NAD+ in your bloodstream. Published bioavailability estimates for oral NMN and NR range widely, and no oral formulation achieves the sustained blood levels that IV administration provides.
IV delivery bypasses the entire gastrointestinal tract. NAD+ enters the bloodstream directly at 100 percent bioavailability — no conversion steps, no absorption losses, no hepatic degradation. This allows licensed providers to deliver therapeutic doses that produce measurable cellular effects, and it allows patients to feel the impact in a timeframe that oral supplementation simply cannot match.
This does not mean oral precursors are worthless. NMN and NR have legitimate research behind them and may provide modest maintenance support between IV sessions. But for patients seeking meaningful NAD+ replenishment — particularly those starting from a depleted baseline — IV delivery is the most direct and reliable route.
NAD+ therapy works best when guided by data. 42 biomarkers across 10 body systems show exactly where your cellular health needs support.
Book Your ConsultationNAD+ therapy is not a single-indication treatment. Because NAD+ is involved in so many fundamental cellular processes, its replenishment has documented benefits across a range of conditions and goals. Here are the clinical applications where the evidence and clinical outcomes are strongest.
NAD+ is critical for neuronal energy metabolism. Neurons are among the most energy-demanding cells in the body, and they are disproportionately affected by NAD+ depletion. Patients presenting with brain fog — difficulty concentrating, word-finding problems, mental fatigue — frequently report significant cognitive improvement after NAD+ IV therapy. The mechanism is straightforward: restored mitochondrial function in neural tissue means restored processing speed, memory consolidation, and executive function.
When fatigue persists despite adequate sleep, thyroid optimization, and iron repletion, mitochondrial dysfunction is often the missing piece. NAD+ directly fuels the electron transport chain, and restoring adequate levels can produce a noticeable energy shift that patients describe as qualitatively different from caffeine or stimulants — not a spike and crash, but a sustained, steady improvement in baseline energy.
High-intensity training generates significant oxidative stress and tissue damage. Recovery depends on the body's ability to repair that damage and restore cellular energy stores. NAD+ accelerates both processes: it fuels the DNA repair enzymes that address exercise-induced damage and supports the mitochondrial biogenesis that adapts your cells to increased physical demand. Athletes and active adults using NAD+ therapy report faster recovery between sessions, reduced muscle soreness, and improved endurance.
NAD+ therapy has a decades-long history in addiction medicine. Chronic substance use — particularly alcohol, opioids, and stimulants — severely depletes NAD+ stores. This depletion contributes to the withdrawal symptoms, cravings, cognitive impairment, and fatigue that make early recovery so difficult. High-dose IV NAD+ protocols are used in integrative addiction treatment centers to accelerate detoxification, reduce withdrawal severity, and restore baseline neurological function. This is not a replacement for comprehensive addiction treatment, but it is a powerful biochemical support during the most vulnerable phase of recovery.
Research into NAD+ and neurodegeneration is among the most active areas in aging science. NAD+ depletion has been implicated in the pathology of conditions affecting neural tissue, and preclinical studies have demonstrated that NAD+ replenishment can improve mitochondrial function, reduce neuroinflammation, and support neuronal survival. While this research is still evolving, patients with early-stage cognitive concerns are increasingly exploring NAD+ therapy as part of a broader neuroprotective strategy.
Here is where NAD+ therapy intersects with something we see daily in our practice at THE WELLNESS CO. Many patients come in with symptoms they attribute to hormonal imbalance — fatigue, weight gain, brain fog, low libido, poor sleep — and they are often right. But what most people do not realize is that hormone production itself depends on mitochondrial health.
The steroidogenic pathway — the biochemical process by which your body produces cortisol, estrogen, testosterone, progesterone, and DHEA — begins inside the mitochondria. Cholesterol is transported into the mitochondrial membrane, where it is converted into pregnenolone, the precursor to all steroid hormones. This process is energy-dependent and NAD+-dependent.
When mitochondrial function is compromised by NAD+ depletion, hormone production can decline even when the glands themselves are healthy. This means that some patients with hormone-related symptoms are not dealing with a primary endocrine problem — they are dealing with an energy production problem that is limiting their endocrine output.
This is why the most effective approach to hormone optimization does not look at hormones in isolation. It evaluates the metabolic, mitochondrial, and nutrient foundations that hormone production depends on. NAD+ status is a critical piece of that picture.
If you have never had an NAD+ infusion, here is what the experience typically looks like.
A standard NAD+ IV session runs 2 to 4 hours, depending on the dose. Higher therapeutic doses require slower infusion rates to maintain comfort. This is not a 30-minute drip like a standard vitamin IV — NAD+ requires time to be delivered safely and effectively.
NAD+ infusions produce sensations that other IV therapies do not. Most patients experience some combination of chest warmth or tightness, mild abdominal cramping, and occasional nausea during the infusion. These sensations are dose-dependent and rate-dependent — they are managed by adjusting the drip speed. They are not dangerous and they resolve quickly when the rate is reduced. By the end of the session, most patients report feeling clear-headed, calm, and subtly energized.
Protocols are individualized based on clinical goals and baseline status. A typical initial protocol involves a loading phase of 2 to 4 infusions over 1 to 2 weeks, followed by monthly or bimonthly maintenance sessions. Patients addressing significant depletion — whether from chronic illness, substance recovery, or prolonged stress — may benefit from more frequent sessions during the initial phase.
The most commonly reported effects in the hours and days following an NAD+ infusion include improved mental clarity, more stable energy throughout the day, better sleep quality, and a general sense of restored vitality. These effects are cumulative with repeated sessions — each infusion builds on the cellular restoration achieved by the previous one.
NAD+ therapy administered in isolation is better than no NAD+ therapy at all. But administering it without understanding a patient's full biochemical picture is like fueling an engine without checking the oil, coolant, and transmission fluid. The fuel matters — but it is not the only thing that determines how well the engine runs.
At THE WELLNESS CO., NAD+ therapy is one component within a data-driven approach to cellular and systemic health. Before recommending NAD+, our licensed providers evaluate 42 biomarkers across 10 body systems through the CLARITY diagnostic process. This reveals:
This approach ensures that NAD+ therapy is not just replenishing a depleted molecule — it is restoring it within a system that can actually use it effectively. The combination of NAD+ infusions with peptide therapy, targeted nutrient repletion, and hormone optimization creates a compounding effect that no single intervention achieves alone.
NAD+ therapy is appropriate for a wide range of adults, but it is particularly relevant if you are experiencing any of the following:
The best way to determine whether NAD+ therapy fits your specific situation is to start with a comprehensive evaluation. Your biomarkers tell the story that symptoms alone cannot — and they guide a treatment plan that addresses root causes rather than masking downstream effects.
If you are in the San Diego area and ready to move beyond guesswork, the conversation starts with data. Comprehensive lab work, a diagnostic report built on your specific biochemistry, and a licensed provider who understands how all of these systems connect.
That is what we do at THE WELLNESS CO. in Santee. And NAD+ therapy, when indicated by your labs and clinical picture, is one of the most powerful tools in the toolkit.
NAD+ therapy restores the cellular energy that drives everything — cognition, recovery, hormone production, and aging itself. Start with the data.
Book Your Free Consultation